Rac1-mediated membrane raft localization of PI3K/p110β is required for its activation by GPCRs or PTEN loss
Onur Cizmecioglu,
Jing Ni,
Shaozhen Xie,
Jean J Zhao,
Thomas M Roberts
Affiliations
Onur Cizmecioglu
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States
Jing Ni
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States
Shaozhen Xie
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States
Jean J Zhao
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States
We aimed to understand how spatial compartmentalization in the plasma membrane might contribute to the functions of the ubiquitous class IA phosphoinositide 3-kinase (PI3K) isoforms, p110α and p110β. We found that p110β localizes to membrane rafts in a Rac1-dependent manner. This localization potentiates Akt activation by G-protein-coupled receptors (GPCRs). Thus genetic targeting of a Rac1 binding-deficient allele of p110β to rafts alleviated the requirement for p110β-Rac1 association for GPCR signaling, cell growth and migration. In contrast, p110α, which does not play a physiological role in GPCR signaling, is found to reside in nonraft regions of the plasma membrane. Raft targeting of p110α allowed its EGFR-mediated activation by GPCRs. Notably, p110β dependent, PTEN null tumor cells critically rely upon raft-associated PI3K activity. Collectively, our findings provide a mechanistic account of how membrane raft localization regulates differential activation of distinct PI3K isoforms and offer insight into why PTEN-deficient cancers depend on p110β.